In today’s healthcare market, pharmaceutical companies are expected to demonstrate a commitment to sustainability throughout their operations. Patients, healthcare providers (HCPs) and policymakers are increasingly considering sustainability factors when making purchasing decisions, with many expecting companies to align their practices with environmental and social objectives.
The rising significance of sustainability in healthcare necessitates procurement professionals’ awareness of their suppliers’ environmental practices. Additionally, they need to be able to assess the sustainability of various goods and services. By doing so, they can make informed decisions that support their sustainability goals while meeting their customers’ needs.
There is an increasing focus on environmental, social and governance (ESG) criteria in procurement practices across the EU. The integration of ESG criteria involves assessing technologies’ environmental footprint, considering their potential contribution to sustainability, and aligning with the EU’s commitment to carbon neutrality and the World Health Organization’s call for sustainable healthcare practices.
By embracing this holistic approach, the EU is leading the way in ensuring that environmental sustainability is considered alongside efficacy, safety and cost-effectiveness, ultimately promoting the development of healthcare technologies that contribute to both human health and environmental well-being.
Read the article in full here.
